Abuse-Deterrent 12 HR oxycodone hydrochloride 15 MG Extended Release Oral Tablet [Oxycontin]

RxCUI
1049545
RxNorm name
Abuse-Deterrent 12 HR oxycodone hydrochloride 15 MG Extended Release Oral Tablet [Oxycontin]
Display name
OxyCONTIN XR (Oral Pill)
Full name
Abuse-Deterrent 12 HR oxycodone hydrochloride 15 MG Extended Release Oral Tablet [Oxycontin]
Term type
SBD
Status
Active
Strength
15 mg
Dose form
Abuse-Deterrent 12 HR XR Tab
Route
Oral Pill
Updated
2026-11-02 18:13:15

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012011
Active start
012011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
oxycodone hydrochloride15 MG / 1 EACHoxycodoneoxycodone hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
oxycodone7804

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STR12 HR OxyCONTIN 15 MG Extended Release Oral Tablet1NAMES
RxNorm NameAbuse-Deterrent 12 HR oxycodone hydrochloride 15 MG Extended Release Oral Tablet [Oxycontin]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_IDbfdfe235-d717-4855-a3c8-a13d26dadede1CODES
RxCUI10495451CODES
MMSL_CODEBD223741CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
59011-415-1059011-415OxyContin oxycodone hydrochlorideKnoa Pharma LLCNDA022272
59011-415-2059011-415OxyContin oxycodone hydrochlorideKnoa Pharma LLCNDA022272

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA02227259011-415OxyContin oxycodone hydrochlorideNDAKnoa Pharma LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 6 matching rows.

NDC11, Source, Active table
NDC11SourceActive
59011041510rxnav_ndcsyes
59011041520rxnav_ndcsyes
16590069060rxnav_historical
59011081510rxnav_historical
63629418001rxnav_historical
65505081510rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxyContinOXYCODONE HYDROCHLORIDEKnoa Pharma LLCbfdfe235-d717-4855-a3c8-a13d26dadede2026-06-24Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 59011-415-20
ndc (package): 59011-415-10
ndc (product): 59011-415
ndc11 (package): 59011041510
ndc11 (package): 59011041520
rxcui: 1049545

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bfdfe235-d717-4855-a3c8-a13d26dadedeOxyCONTIN 15 MG 12HR Extended Release Oral Tablet [PSN] · Abuse-Deterrent 12 HR oxycodone hydrochloride 15 MG Extended Release Oral Tablet [Oxycontin] [SBD] · 12 HR Oxycontin 15 MG Extended Release Oral Tablet [SY] · OxyContin 15 MG 12 HR Extended Release Oral Tablet [SY]443These highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 195020260501

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
bfdfe235-d717-4855-a3c8-a13d26dadedeThese highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950Knoa Pharma LLC | Knoa Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC20260624
bfdfe235-d717-4855-a3c8-a13d26dadedeThese highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950Knoa Pharma LLC | Knoa Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC20260501
bfdfe235-d717-4855-a3c8-a13d26dadedeThese highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950Knoa Pharma LLC | Knoa Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC20260326
bfdfe235-d717-4855-a3c8-a13d26dadedeThese highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950Purdue Pharma LP | Purdue Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC20260130
bfdfe235-d717-4855-a3c8-a13d26dadedeThese highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950Purdue Pharma LP | Purdue Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC20251231
3471277b-ac3c-4d60-8880-8004fd333ddbNational Council for Prescription Drug Programs20120724
62850c47-539a-4952-942c-0e6669621647National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02AANatural opium alkaloidsATC1-4oxycodone
FDASPLN0000175690Opioid AgonistEPChas_epcoxycodone
FDASPLN0000175684Full Opioid AgonistsMOAhas_moaoxycodone
MEDRTD010098OxycodoneCHEMhas_ingredientoxycodone hydrochloride
MEDRTD010098OxycodoneCHEMhas_ingredientoxycodone
MEDRTD001249AsthmaDISEASEci_withoxycodone
MEDRTD001249AsthmaDISEASEci_withoxycodone hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withoxycodone
MEDRTD004342Drug HypersensitivityDISEASEci_withoxycodone hydrochloride
MEDRTD007415Intestinal ObstructionDISEASEci_withoxycodone
MEDRTD007415Intestinal ObstructionDISEASEci_withoxycodone hydrochloride
MEDRTD007418Intestinal Pseudo-ObstructionDISEASEci_withoxycodone hydrochloride
MEDRTD007418Intestinal Pseudo-ObstructionDISEASEci_withoxycodone
MEDRTD010149Postoperative PainDISEASEmay_treatoxycodone hydrochloride
MEDRTD010149Postoperative PainDISEASEmay_treatoxycodone
MEDRTD011247PregnancyDISEASEci_withoxycodone hydrochloride
MEDRTD011247PregnancyDISEASEci_withoxycodone
MEDRTD012131Respiratory InsufficiencyDISEASEci_withoxycodone hydrochloride
MEDRTD012131Respiratory InsufficiencyDISEASEci_withoxycodone
MEDRTN0000175684Full Opioid AgonistsMOAhas_moaoxycodone hydrochloride
MEDRTN0000175684Full Opioid AgonistsMOAhas_moaoxycodone
MEDRTN0000175439AnalgesiaPEhas_peoxycodone
MEDRTN0000175439AnalgesiaPEhas_peoxycodone hydrochloride
MEDRTN0000008635Decreased GI MotilityPEhas_peoxycodone
MEDRTN0000008635Decreased GI MotilityPEhas_peoxycodone hydrochloride
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_peoxycodone hydrochloride
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_peoxycodone
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_peoxycodone
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_peoxycodone hydrochloride
MEDRTN0000009353Increased Histamine ProductionPEhas_peoxycodone
MEDRTN0000009353Increased Histamine ProductionPEhas_peoxycodone hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH15 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUALITATIVE_DISTINCTIONAbuse-Deterrent
ATTRIBUTESQUANTITY12 HR
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE2
CODESNDANDA022272
NAMESPrescribable SynonymOxyCONTIN 15 MG 12HR Extended Release Oral Tablet
NAMESTallman Synonym12 HR OxyCONTIN 15 MG Extended Release Oral Tablet
NAMESTallman SynonymAbuse-Deterrent 12 HR oxyCODONE hydrochloride 15 MG Extended Release Oral Tablet [OxyCONTIN]
NAMESTallman SynonymOxyCONTIN 15 MG 12 HR Extended Release Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon